F2 and COVID-19: Disseminated intravascular coagulation is a coagulopathy characterized by thrombocytopenia, elevated D-dimer levels, prolonged prothrombin time, and reduced fibrinogen; it has been associated with a poor prognosis in COVID-19 patients (34, 35).